A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine
Clinical trial NCT04036526 · UNKNOWN
Trial details
- NCT number
- NCT04036526
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2020-05-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.